tuftsin has been researched along with Leukemia P388 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoscato, AA; Babcock, GF; Banks, RA; Nishioka, K; Phillips, JH | 1 |
1 review(s) available for tuftsin and Leukemia P388
| Article | Year |
|---|---|
Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier.
Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Candidiasis; Cytotoxicity, Immunologic; Humans; Killer Cells, Natural; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lymphocyte Activation; Macrophages; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Neoplasm Transplantation; Neutrophils; Phagocytosis; Receptors, Cell Surface; Receptors, Immunologic; Tuftsin | 1984 |